ACE inhibitors in patients with heart failure

ACE inhibitors in patients with heart failure

.

Saved in:

Bibliographic Details
Main Authors:	O. P. Shevchenko, A. O. Shevchenko
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2008-10-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1632
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MICROCIRCULATION IN CHRONIC HEART FAILURE PATIENTS TREATED WITH ACE INHIBITORS AND DIURETICS
by: Yu. I. Gurfinkel, et al.
Published: (2011-04-01)

COMPARISON OF ACE INHIBITOR (FOSINOPRIL) AND Β-ADRENOBLOCKER (ATENOLOL) EFFECTS ON AUTONOMIC REGULATION OF THE HEART IN PATIENTS WITH ARTERIAL HYPERTENSION
by: A. R. Kiselyov, et al.
Published: (2016-01-01)

ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES
by: Y. A. Karpov
Published: (2015-12-01)

ACE INHIBITOR ZOFENOPRIL IN COMPLEX THERAPY OF CHRONIC HEART FAILURE AND DILATED CARDIOMYOPATHY
by: Z. T. Astakhova, et al.
Published: (2010-04-01)

ACE inhibitor lisinopril influence on left ventricular diastolic dysfunction and endothelial response in hypertensive patients with or without chronic heart failure
by: A. D. Kuimov, et al.
Published: (2004-06-01)

ACE inhibitor in complex therapy of functional class II-III chronic heart failure in patients with chronic obstructive pulmonary disease
by: A. G. Evdokimova, et al.
Published: (2005-12-01)

Are there benefits of low doses of ACE inhibitors, MRAs, diuretics and statins in the treatment of heart failure?
by: V. А. Lysenko
Published: (2021-07-01)

COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Clinical and cost-effectiveness of ACE inhibitors in patients with arterial hypertension and coronary heart disease
by: O. Yu. Korennova, et al.
Published: (2008-08-01)

Venous thromboembolism in patients with heart failure
by: O. V. Averkov, et al.
Published: (2011-08-01)

EVIDENCE-BASED CHOICE OF ACE INHIBITORS
by: G. E. Gendlin, et al.
Published: (2012-08-01)

Comprehensive non-invasive evaluation of the functional status of patients with chronic heart failure
by: N. N. Koloskova, et al.
Published: (2024-04-01)

РАРР-А AND ATHEROSCLEROTIC PLAQUE INJURY IN PATIENTS WITH CORONARY HEART DISEASE
by: O. P. Shevchenko, et al.
Published: (2011-04-01)

ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION
by: M. P. Metrova, et al.
Published: (2016-01-01)

SIGNIFICANCE OF BASELINE ACE ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME WHEN ADMINISTRATION OF ACE INHIBITORS AND IMIDAZOLINE AGONISTS IS CONSIDERED
by: T. V. Aparina, et al.
Published: (2001-04-01)

EFFECT OF ACE INHIBITOR AND RECEPTOR ANTAGONIST OF TYPE 1 ANGIOTENSIN II ON HEMODYNAMICS AND MORPHO-FUNCTIONAL PARAMETERS OF THE HEART IN PATIENTS WITH HEART FAILURE ON A BACKGROUND OF CORONARY HEART DISEASE COMBINED WITH TYPE 2 DIABETES
by: Z. V. BITAROVA, et al.
Published: (2017-09-01)

Clinical value of soluble CD40 ligand in coronary heart disease patients
by: O. P. Shevchenko, et al.
Published: (1970-01-01)

ACE inhibitors in patients with acute myocardial infarction
by: S. N. Tereshchenko, et al.
Published: (2005-08-01)

ACE inhibitors and myocardial remodeling in patients with arterial hypertension and atrial fibrillation
by: O. N. Miller, et al.
Published: (2007-10-01)

CD40 ligand in coronary heart disease patients with Type 2 diabetes mellitus
by: O. P. Shevchenko, et al.
Published: (2006-10-01)

ACE inhibitor trandolapril effectiveness in arterial hypertension
by: K. I. Tebloev, et al.
Published: (2008-04-01)

ACE phenotyping in human heart.
by: Victoria E Tikhomirova, et al.
Published: (2017-01-01)

Galectin-3 in heart recipients
by: A. A. Ulybysheva, et al.
Published: (2019-07-01)

Pharmacology of modern ACE inhibitors: moexipril example
by: D. P. Khloponin, et al.
Published: (2007-10-01)

Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01)

ST2 IN REJECTION OF THE TRANSPLANTED HEART
by: O. P. Shevchenko, et al.
Published: (2016-01-01)

NON-LIPID MECHANISMS OF STATINS ACTION FOR HEART TRANSPLANT RECIPIENTS
by: А. О. Shevchenko, et al.
Published: (2013-05-01)

ACE Inhibitor-Induced Angioedema of the Bowel
by: Tabitha Campbell, et al.
Published: (2010-01-01)

Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)

ACE inhibitors in the treatment of paroxysmal atrial fibrillation
by: B. A. Tatarsky
Published: (2005-06-01)

New potential of ACE inhibitors in clinical practice
by: D. V. Nebieridze, et al.
Published: (2010-10-01)

The role of frailty in selecting patients for heart transplantation
by: N. N. Koloskova, et al.
Published: (2022-07-01)

Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges
by: Seyyed M. R. Kazemi-Bajestani, et al.
Published: (2012-01-01)

NEW EVALUATION METHOD FOR EFFICACY OF HYPOTENSIVE TREATMENT WITH ACE INHIBITORS
by: V. V. Shkarin, et al.
Published: (2003-06-01)

Pregnancy-associated plasma protein – a new biochemical marker of acute coronary syndrome and poor prognosis predictor in coronary heart disease patients
by: O. P. Shevchenko, et al.
Published: (2006-08-01)

ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

CD40 ligand level – vascular inflammation activity and long6term prognosis in coronary heart disease patients
by: O. P. Shevchenko, et al.
Published: (2008-02-01)

Comparative efficacy of ace inhibitor spirapril in hypertensive patients from various age groups
by: L. A. Sokolova, et al.
Published: (2006-06-01)

VASCULAR ENDOTHELIAL GROWTH FACTORS IN HEART TRANSPLANT REJECTIONS
by: O. P. Shevchenko, et al.
Published: (2015-05-01)

ACE inhibitors as a risk factor for hypoglycemia
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2011-12-01)